Related references
Note: Only part of the references are listed.Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study
Andrea Ciavattini et al.
BMJ OPEN (2019)
Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
Clare A. Aitken et al.
BMC MEDICINE (2019)
Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial
Nicole J. Polman et al.
LANCET ONCOLOGY (2019)
Quality of life assumptions determine which cervical cancer screening strategies are cost-effective
Inge M. C. M. de Kok et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country
Louiza S. Velentzis et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial
Darrel A. Cook et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows
Cornelis Johannes Jacobus Huijsmans et al.
BMC CANCER (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
Matejka Rebolj et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
Jie-Bin Lew et al.
PLOS ONE (2016)
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis
Steffie K. Naber et al.
PLOS ONE (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands
Maaike G. Dijkstra et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?
Kirsten Rozemeijer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
J. van Rosmalen et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
E. A. Burger et al.
BRITISH JOURNAL OF CANCER (2012)
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
Inge M. C. M. de Kok et al.
BRITISH MEDICAL JOURNAL (2012)
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
Henry C. Kitchener et al.
EUROPEAN JOURNAL OF CANCER (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
Cervical adenocarcinoma: Moving towards better prevention
Muhieddine Seoud et al.
VACCINE (2011)
HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
Murat Gok et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months
Saskia Bulk et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Monitoring a national cancer prevention program: Successful changes in cervical cancer screening in the Netherlands
Matejka Rebolj et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
Share Paper
